Feng-Wei Wang

897 total citations
11 papers, 663 citations indexed

About

Feng-Wei Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Feng-Wei Wang has authored 11 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Feng-Wei Wang's work include MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers) and Epigenetics and DNA Methylation (3 papers). Feng-Wei Wang is often cited by papers focused on MicroRNA in disease regulation (4 papers), Circular RNAs in diseases (3 papers) and Epigenetics and DNA Methylation (3 papers). Feng-Wei Wang collaborates with scholars based in China and Hong Kong. Feng-Wei Wang's co-authors include Dan Xie, Xiao-Han Jin, Rui‐Hua Xu, Jing‐Ping Yun, Jie-Wei Chen, Xiao-Peng Tian, Qing-Qing Cai, Mei Li, Mu-Yan Cai and Jiaxing Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Scientific Reports and Virology.

In The Last Decade

Feng-Wei Wang

11 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng-Wei Wang China 11 545 478 72 52 49 11 663
Xinhui Liu China 13 425 0.8× 319 0.7× 99 1.4× 76 1.5× 59 1.2× 27 579
Xiao-Han Jin China 6 398 0.7× 324 0.7× 49 0.7× 41 0.8× 36 0.7× 7 478
Zenia Tiang Singapore 9 515 0.9× 343 0.7× 49 0.7× 48 0.9× 20 0.4× 16 663
Minghui Zhang China 12 321 0.6× 173 0.4× 132 1.8× 50 1.0× 34 0.7× 19 494
Manuela Lanzafame Italy 11 342 0.6× 200 0.4× 67 0.9× 55 1.1× 47 1.0× 21 496
Kar Lok Kong Hong Kong 7 725 1.3× 383 0.8× 122 1.7× 27 0.5× 43 0.9× 8 872
Lang Fang China 9 440 0.8× 350 0.7× 52 0.7× 49 0.9× 36 0.7× 16 544
Ke Cao China 11 448 0.8× 465 1.0× 54 0.8× 35 0.7× 28 0.6× 11 577

Countries citing papers authored by Feng-Wei Wang

Since Specialization
Citations

This map shows the geographic impact of Feng-Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng-Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng-Wei Wang more than expected).

Fields of papers citing papers by Feng-Wei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng-Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng-Wei Wang. The network helps show where Feng-Wei Wang may publish in the future.

Co-authorship network of co-authors of Feng-Wei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Feng-Wei Wang. A scholar is included among the top collaborators of Feng-Wei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng-Wei Wang. Feng-Wei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Tian, Xiao-Peng, Xiao-Han Jin, Mei Li, et al.. (2019). Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Theranostics. 9(7). 1965–1979. 194 indexed citations
2.
Ma, Ning-Fang, et al.. (2019). Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma. International Journal of Gynecological Cancer. 29(8). 1280–1284. 11 indexed citations
3.
Zhou, Chi, Feng-Wei Wang, Tuo Hu, et al.. (2019). circCAMSAP1 Promotes Tumor Growth in Colorectal Cancer via the miR-328-5p/E2F1 Axis. Molecular Therapy. 28(3). 914–928. 115 indexed citations
4.
Wang, Feng-Wei, Chenhui Cao, Kai Han, et al.. (2018). APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production. Journal of Clinical Investigation. 129(2). 727–743. 131 indexed citations
5.
Jin, Xiao-Han, Mu-Yan Cai, Jie-Wei Chen, et al.. (2017). AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma. Cancer Letters. 414. 71–80. 36 indexed citations
6.
Liao, Yiji, Mu-Yan Cai, Ning-Fang Ma, et al.. (2017). Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis. Stem Cells. 36(2). 180–191. 26 indexed citations
7.
Cai, Mu-Yan, Feng-Wei Wang, Chang-Peng Li, et al.. (2016). Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma. Chinese Journal of Cancer. 35(1). 80–80. 14 indexed citations
8.
Li, Xiangdong, Pei Dong, Jie-Wei Chen, et al.. (2016). Overexpression of RNF2 Is an Independent Predictor of Outcome in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. Scientific Reports. 6(1). 20894–20894. 16 indexed citations
9.
Li, Chang-Peng, Mu-Yan Cai, Shi-Juan Mai, et al.. (2016). CLDN14 is epigenetically silenced by EZH2-mediated H3K27ME3 and is a novel prognostic biomarker in hepatocellular carcinoma. Carcinogenesis. 37(6). 557–566. 35 indexed citations
10.
Zhang, Jiaxing, Dong Qian, Feng-Wei Wang, et al.. (2012). MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy. Cancer Letters. 329(1). 91–98. 68 indexed citations
11.
Wang, Feng-Wei, Xian-rui Wu, Yi-Ji Liao, et al.. (2011). Heat shock factor 1 upregulates transcription of Epstein–Barr Virus nuclear antigen 1 by binding to a heat shock element within the BamHI-Q promoter. Virology. 421(2). 184–191. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026